275 related articles for article (PubMed ID: 36884035)
1. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.
Kim S; Kong JH; Lee Y; Lee JY; Kang TW; Kong TH; Kim MH; You SH
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012817. PubMed ID: 36884035
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionation for clinically localized prostate cancer.
Hickey BE; James ML; Daly T; Soh FY; Jeffery M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for advanced or metastatic urothelial carcinoma.
Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279
[TBL] [Abstract][Full Text] [Related]
7. Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
Rosenberg JE; Jung JH; Lee H; Lee S; Bakker CJ; Dahm P
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013677. PubMed ID: 34365635
[TBL] [Abstract][Full Text] [Related]
8. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.
Lawrie TA; Green JT; Beresford M; Wedlake L; Burden S; Davidson SE; Lal S; Henson CC; Andreyev HJN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012529. PubMed ID: 29360138
[TBL] [Abstract][Full Text] [Related]
9. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882
[TBL] [Abstract][Full Text] [Related]
10. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
[TBL] [Abstract][Full Text] [Related]
11. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
12. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
13. Primary cryotherapy for localised or locally advanced prostate cancer.
Jung JH; Risk MC; Goldfarb R; Reddy B; Coles B; Dahm P
Cochrane Database Syst Rev; 2018 May; 5(5):CD005010. PubMed ID: 29845595
[TBL] [Abstract][Full Text] [Related]
14. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
[TBL] [Abstract][Full Text] [Related]
15. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
[TBL] [Abstract][Full Text] [Related]
16. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Philippou YA; Kuntz GM; Konety BR; Gupta S; Lamb AD; Dahm P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012816. PubMed ID: 30320443
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
[TBL] [Abstract][Full Text] [Related]
19. Extended-field radiotherapy for locally advanced cervical cancer.
Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
